These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 9496572

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Tuberculosis of the middle ear: a rare extrapulmonary manifestation].
    Schütte W, Berghaus A, Schütte A.
    Dtsch Med Wochenschr; 1996 Dec 06; 121(49):1551. PubMed ID: 8998926
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tuberculosis after renal transplantation.
    Kaaroud H, Beji S, Boubaker K, Abderrahim E, Ben Hamida F, Ben Abdallah T, El Younsi F, Ben Moussa F, Kheder A.
    Transplant Proc; 2007 May 06; 39(4):1012-3. PubMed ID: 17524877
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.
    Tam CM, Chan SL, Kam KM, Goodall RL, Mitchison DA.
    Int J Tuberc Lung Dis; 2002 Jan 06; 6(1):3-10. PubMed ID: 11931398
    [Abstract] [Full Text] [Related]

  • 10. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG, Chernousova LN, Andreevskaia SN, Nikolaeva GM.
    Probl Tuberk Bolezn Legk; 2004 Jan 06; (3):32-7. PubMed ID: 15338898
    [Abstract] [Full Text] [Related]

  • 11. [Efficiency of shorter chemotherapy courses for intrathoracic tuberculosis in children].
    Iukhimenko NV.
    Probl Tuberk; 2000 Jan 06; (3):20-3. PubMed ID: 10900978
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S.
    East Afr Med J; 1999 Jun 06; 76(6):307-13. PubMed ID: 10750516
    [Abstract] [Full Text] [Related]

  • 14. Genitourinary tuberculosis in pediatric urological practice.
    Nerli RB, Kamat GV, Alur SB, Koura A, Vikram P, Amarkhed SS.
    J Pediatr Urol; 2008 Aug 06; 4(4):299-303. PubMed ID: 18644534
    [Abstract] [Full Text] [Related]

  • 15. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C, Vargas MH, Martínez-Rossier LA, Torres-Cruz A, Villarreal-Velarde H.
    Int J Tuberc Lung Dis; 2002 Dec 06; 6(12):1102-9. PubMed ID: 12546119
    [Abstract] [Full Text] [Related]

  • 16. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR, Sifakis F, Montes de Oca R, Cronin WA, Doherty MC, Federline L, Bur S, Walsh T, Karney W, Milman J, Baruch N, Adelakun A, Dorman SE.
    Arch Intern Med; 2006 Sep 25; 166(17):1863-70. PubMed ID: 17000943
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
    Dekker TG, Lötter AP.
    Int J Tuberc Lung Dis; 2003 Mar 25; 7(3):205-6. PubMed ID: 12661831
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].
    Ouedraogo M, Ouedraogo SM, Diagbouga S, Coulibaly G, Achi V, Domoua K, N'Dathz M, Yapi A.
    Rev Mal Respir; 2000 Apr 25; 17(2):477-80. PubMed ID: 10859766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.